POLE and neoplasm: Synergistic transcriptomic and proteomic analyses revealed that POLEP286R mutation-specific T cells significantly activated tumor- and immune-related signaling pathways upon recognition of POLE neoantigens, further confirming the possibility of neoantigen production by mutations at this locus.